Search

Search Constraints

You searched for: Author/Creator Merschhemke, Martin

Search Results

2. AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study. Issue 13 (12th July 2013)

3. AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study. Issue 13 (12th July 2013)

5. Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study. Issue 3 (30th January 2018)

6. Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS. Issue 1 (29th August 2019)

7. Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study. Issue 5 (4th March 2020)

8. Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study. (July 2022)

10. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial. Issue 8 (August 2018)